10 results on '"Yonan, Charles"'
Search Results
2. Poster 62 Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect in Patients with Traumatic Brain Injury: PRISM‐II
3. P3-290: Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Examination of cns-ls outcomes in a 12-week open-label trial (PRISM II)
4. O4-09-06: Dextromethorphan/quinidine for treatment of pseudobulbar affect in patients with dementia: Treatment effects by concomitant antidepressant use in a 12-week open-label trial (PRISM II)
5. P1-300: Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Comparison of patient-reported ratings to those of caregiver proxies in a 12-week open-label trial (PRISM II)
6. P4‐341: QUANTIFYING THE IMPACT OF PSEUDOBULBAR AFFECT (PBA) ON HEALTH‐RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH ALZHEIMER'S DISEASE TREATED WITH NUEDEXTA OR CONVENTIONAL MEDICATION
7. P4-336: PREVALENCE AND CORRELATES OF PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN NURSING HOME RESIDENTS
8. P4‐359: PRISM II: AN OPEN‐LABEL STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF DEXTROMETHORPHAN 20 MG/QUINIDINE 10 MG (NUEDEXTA®) IN PSEUDOBULBAR AFFECT (PBA) SECONDARY TO DEMENTIA, STROKE, OR TRAUMATIC BRAIN INJURY (TBI)–EARLY RESULTS OF TRIAL
9. P3-288: A study to assess the safety, tolerability and effectiveness of NUEDEXTA (dextromethorphan 20 mg/quinidine 10 mg) in the treatment of pseudobulbar affect (PBA) [PRISM-II]
10. Poster 345 Comparison of Rehabilitation Services Utilization and Costs Between Post‐Stroke Patients With and Without Inferred Pseudobulbar Affect
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.